P-091 Patients with Inflammatory Bowel Disease Who Develop Secondary Systemic Amyloidosis Have Increased In-Hospital Mortality

Background:Systemic AA amyloidosis has been reported as a rare but severe complication of Inflammatory Bowel disease (IBD), particularly of Crohn's disease (CD). It is characterized by extracellular deposition of fibrillar proteins in organs leading to organ dysfunction. The aim of this study is to